 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Bone Biologics announces closing of registered direct offering

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced registered direct offering priced...

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 12% to $0.54 Monday morning on downward momentum after the company last week announced it's conducting a public offering and private...

Why Bone Biologics Stock (BBLG) Is Falling Sharply

Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 38% to $0.48 Friday morning after the company announced it's conducting a public offering and private placement to sell over a million...

Why Bone Biologics Stock (BBLG) Is Getting Obliterated Friday

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that it has entered into a definitive agreement for the issuance and sale of...

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Co. (NASDAQ:BBLG  Get Free Report) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 9,300 shares, a...

Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, provides an update on its clinical development initiatives with its NB1 bone graft device...

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Insider Buying: CFO Deina Walsh Acquires 8,000 Shares of Bone Biologics Corp (BBLG)

CEO Jeff Frelick Buys 9,500 Shares of Bone Biologics Corp (BBLG)

Bone Biologics Co. (NASDAQ:BBLG Get Free Report) saw a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 10,800 shares, a decline of 57.0% from the July 31st total of 25,100 shares. Based on an average trading volume of 384,800 shares, the ...

Bone Biologics Co. (NASDAQ:BBLG) Sees Large Decrease in Short Interest

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Watchers	2,302
52-Wk Low	$0.40
52-Wk High	$13.20

Market Cap	$1.29M
Volume (M)	323,749.00
52-Wk High	$13.20
52-Wk Low	$0.40

BBLG Bone Biologics Corp

About

Feed

News

Fundamentals